VACCINATIONS: All vaccinations delivered by suitably trained pharmacists have always been covered by indemnity insurance as part of the standard PDA membership apart from Covid-19. For new membership renewals after January 1st, 2026, Covid-19 vaccinations are now also automatically covered.

Home  »   Latest News   »   PDA issues final reminder on Boots Pension Scheme complaints

PDA issues final reminder on Boots Pension Scheme complaints

Members of the Boots Pension Scheme are reminded that they should have lodged a case through the Internal Disputes Resolution Procedure (IDRP) if they wish to complain about the 2023 changes to that scheme.

Mon 1st December 2025 The PDA

In 2023, the Boots Pension Scheme was ‘bought in’ with Legal & General. This means that the Trustee used the scheme assets to purchase an insurance contract which covers the benefits payable from the scheme. As part of the buy-in, the ability to take an unreduced pension at age 60 was removed from the scheme.

Many PDA members, currently or previously employed at Boots, and with pension benefits in the ‘Boots Pension Scheme’, approached the PDA for assistance. The PDA obtained expert advice and supported members with making formal complaints.

When the complaints were not resolved at stage one or stage two of the Internal Disputes Resolution Procedure, the PDA supported members in escalating their complaint to the Pensions Ombudsman (TPO).

Following discussions with the ombudsman, it was agreed that as there are many hundreds of members making complaints about the same issues, including but not limited to pharmacists. The TPO would take a lead case(s) approach to complaints.

The outcome of the lead complaint determinations will inform the Trustee and Company of TPO’s views on the issues that affect members generally, and how other complaints would likely be determined if they were to reach TPO.

Two lead cases have been accepted, which between them cover all the core issues identified by the relevant parties. It is expected that the determinations in the two lead complaints will cover all issues for the vast majority of potentially affected members. The lead case from Mr F, was submitted with the support of the PDA.

Alongside the lead case approach, the company, trustee and Boots have agreed that further updates should be led by the TPO. Latest information and some FAQ’s are therefore available on the TPO website here. PDA members who want a latest update are directed to visit the TPO website.

This article is a final reminder from the PDA to members of the scheme of the Pensions Ombudsman’s direction that they should make any complaint to the Trustee under the scheme’s internal dispute resolution procedure (IDRP) now if they wish their own case to be considered. You can read more about this on the Pension Ombudsman’s website. There is more information, including template letters for complaints in previous articles from the PDA on this topic.

Learn more

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)